Detalhe da pesquisa
1.
Screening for depression in cancer patients receiving radiotherapy: Feasibility and identification of effective tools in the NRG Oncology RTOG 0841 trial.
Cancer;
123(3): 485-493, 2017 Feb 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27861753
2.
TITAN: phase III study of doxorubicin/cyclophosphamide followed by ixabepilone or paclitaxel in early-stage triple-negative breast cancer.
Breast Cancer Res Treat;
164(3): 649-658, 2017 Aug.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28508185
3.
A multisite, community oncology-based randomized trial of a brief educational intervention to increase communication regarding complementary and alternative medicine.
Cancer;
119(19): 3514-22, 2013 Oct 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-23824945
4.
Psychological Treatment for Patients Receiving Radiation: Results of NRG Oncology/RTOG 0841.
Int J Radiat Oncol Biol Phys;
110(4): 962-972, 2021 07 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33567304
5.
Paired Phase II Studies of Erlotinib/Bevacizumab for Advanced Bronchioloalveolar Carcinoma or Never Smokers With Advanced Non-Small-cell Lung Cancer: SWOG S0635 and S0636 Trials.
Clin Lung Cancer;
19(1): 84-92, 2018 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28801183
6.
Phase II trial of ixabepilone and carboplatin with or without bevacizumab in patients with previously untreated advanced non-small-cell lung cancer.
Lung Cancer;
78(1): 70-5, 2012 Oct.
Artigo
em Inglês
| MEDLINE
| ID: mdl-22947511
7.
A phase III, randomized, placebo-controlled, double-blind trial of flaxseed for the treatment of hot flashes: North Central Cancer Treatment Group N08C7.
Menopause;
19(1): 48-53, 2012 Jan.
Artigo
em Inglês
| MEDLINE
| ID: mdl-21900849
8.
Sorafenib in platinum-treated patients with extensive stage small cell lung cancer: a Southwest Oncology Group (SWOG 0435) phase II trial.
J Thorac Oncol;
5(11): 1835-40, 2010 Nov.
Artigo
em Inglês
| MEDLINE
| ID: mdl-20881645
9.
Paclitaxel/carboplatin/etoposide versus gemcitabine/irinotecan in the first-line treatment of patients with carcinoma of unknown primary site: a randomized, phase III Sarah Cannon Oncology Research Consortium Trial.
Cancer J;
16(1): 70-5, 2010.
Artigo
em Inglês
| MEDLINE
| ID: mdl-20164695